A screening of dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir

被引:14
作者
Danve, C [1 ]
Morfin, F [1 ]
Thouvenot, D [1 ]
Aymard, M [1 ]
机构
[1] Virol Lab, F-69373 Lyon 08, France
关键词
screening dye-uptake assay; herpes simplex virus; acyclovir susceptibility;
D O I
10.1016/S0166-0934(02)00103-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The widespread use of acyclovir (ACV) could increase the prevalence of herpes simplex virus (HSV) ACV-resistant isolates, and a screening assay are thus important for routine surveillance of the ACV susceptibility of HSV. A screening dye-uptake assay was developed, based on the conventional dye-uptake assay [J. Biol. Stand. 14 (1986) 201]. The susceptibility of HSV was measured by testing two virus dilutions (10(-1) and 10(-2)) against two ACV concentrations (5 and 10 muM) on Vero cells and expressed as a reduced percentage of viral replication. The reproducibility was evaluated with HSV1 and HSV2 ACV-sensitive and ACV-resistant reference strains introduced as controls in successive series. The dye-uptake by Vero cells, the growth capacity of the HSV strains and the reduction of the viral replication in the presence of acyclovir varied by less than 14, 20 and 30%, respectively. This assay allowed the detection of a heterogenous population containing as few as 20% of ACV-resistant strain. The screening test was applied to 500 HSV isolates in a prospective study, and over 95% of the HSV isolates tested were characterised using a single test. This test appeared to be half the cost and much easier to carry out than the conventional dye-uptake assay, and consequently is well suited for large scale surveillance. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:207 / 217
页数:11
相关论文
共 32 条
[1]   SIMPLIFIED TEST FOR DETECTING THE RESISTANCE OF HERPES-SIMPLEX VIRUS TO ACYCLOVIR [J].
AGUT, H ;
AUBIN, JT ;
INGRAND, D ;
BLANC, S ;
CLAYTON, AL ;
CHANTLER, SM ;
HURAUX, JM .
JOURNAL OF MEDICAL VIROLOGY, 1990, 31 (03) :209-214
[2]   Resistant herpes simplex virus type 1 infection:: An emerging concern after allogeneic stem cell transplantation [J].
Chen, Y ;
Scieux, C ;
Garrait, V ;
Socié, G ;
Rocha, V ;
Molina, JM ;
Thouvenot, D ;
Morfin, F ;
Hocqueloux, L ;
Garderet, L ;
Espérou, H ;
Sélimi, F ;
Devergie, A ;
Leleu, G ;
Aymard, M ;
Morinet, F ;
Gluckman, E ;
Ribaud, P .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :927-935
[3]   Survey of resistance of herpes simplex virus to acyclovir in northwest England [J].
Christophers, J ;
Clayton, J ;
Craske, J ;
Ward, R ;
Collins, P ;
Trowbridge, M ;
Darby, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :868-872
[4]   SENSITIVITY MONITORING OF HERPES-SIMPLEX VIRUS ISOLATES FROM PATIENTS RECEIVING ACYCLOVIR [J].
COLLINS, P ;
OLIVER, NM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :103-112
[5]  
COLLINS P, 1993, J MED VIROL, P58, DOI 10.1002/jmv.1890410512
[6]  
Collins P., 1991, REV MED VIROL, V1, P19
[7]   Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents [J].
Cotarelo, M ;
Catalán, P ;
Sánchez-Carrillo, C ;
Menasalvas, A ;
Cercenado, E ;
Tenorio, A ;
Bouza, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (05) :705-708
[8]   Rapid screening tests for determining in vitro susceptibility of herpes simplex virus clinical isolates [J].
de la Iglesia, P ;
Melón, S ;
López, B ;
Rodriguez, M ;
Blanco, MI ;
Mellado, P ;
de Oña, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (08) :2389-2391
[9]   HERPES-SIMPLEX VIRUS RESISTANT TO ACYCLOVIR - A STUDY IN A TERTIARY CARE CENTER [J].
ENGLUND, JA ;
ZIMMERMAN, ME ;
SWIERKOSZ, EM ;
GOODMAN, JL ;
SCHOLL, DR ;
BALFOUR, HH .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :416-422
[10]   ACYCLOVIR-RESISTANT HERPES-SIMPLEX VIRUS-INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
ERLICH, KS ;
MILLS, J ;
CHATIS, P ;
MERTZ, GJ ;
BUSCH, DF ;
FOLLANSBEE, SE ;
GRANT, RM ;
CRUMPACKER, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :293-296